Journal article · 2010

Abstract LB-31: Drug combination studies: theory and analysis

Mark S. Hixon

Cancer Research, 70(8_Supplement), LB–31 · Published 1 April 2010 · DOI 10.1158/1538-7445.am10-lb-31

View at the publisherCite this paper

In brief

“Abstract LB-31: Drug combination studies: theory and analysis” is a 2010 journal article by Mark S. Hixon, published in Cancer Research. OpenAlex counts 1 citations as of 16 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Authors
1

Abstract

A novel method for the graphical analysis of drug combination studies is presented. This method, Delta Plot Analysis, addresses the shortcomings of Isobolograms and Combination Index determinations. By use of this method, one may choose either a Bliss Independence or Loewe Additivity model and conduct the analysis. The method is comparative in nature, plotted as… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hixon, M. S. (2010). Abstract LB-31: Drug combination studies: theory and analysis. Cancer Research, 70(8_Supplement), LB–31. https://doi.org/10.1158/1538-7445.am10-lb-31

MLA 9

Hixon, Mark S. “Abstract LB-31: Drug combination studies: theory and analysis.” Cancer Research, vol. 70, no. 8_Supplement, 2010, pp. LB–31. https://doi.org/10.1158/1538-7445.am10-lb-31.

Chicago

Hixon, Mark S. 2010. “Abstract LB-31: Drug combination studies: theory and analysis.” Cancer Research 70 (8_Supplement): LB–31. https://doi.org/10.1158/1538-7445.am10-lb-31.

Harvard

Hixon, M. S. (2010) ‘Abstract LB-31: Drug combination studies: theory and analysis’, Cancer Research, 70(8_Supplement), pp. LB–31. doi:10.1158/1538-7445.am10-lb-31.

IEEE

M. S. Hixon, “Abstract LB-31: Drug combination studies: theory and analysis,” Cancer Research, vol. 70, no. 8_Supplement, pp. LB–31, 2010, doi: 10.1158/1538-7445.am10-lb-31.

BibTeX

@article{hixon2010abstract,
  title     = {{Abstract LB-31: Drug combination studies: theory and analysis}},
  author    = {Hixon, Mark S.},
  journal   = {Cancer Research},
  year      = {2010},
  volume    = {70},
  number    = {8_Supplement},
  pages     = {LB--31},
  doi       = {10.1158/1538-7445.am10-lb-31},
  url       = {https://doi.org/10.1158/1538-7445.am10-lb-31}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • synergistic effect
  • antagonism
  • Bliss independence model
  • isobologram
  • combination index
  • cell survival
  • dose-response curves
  • experimental uncertainty

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Hixon, M. S. (2010). Abstract LB-31: Drug combination studies: theory and analysis. Cancer Research, 70(8_Supplement), LB–31. https://doi.org/10.1158/1538-7445.am10-lb-31

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mark S. Hixon.

What is the DOI of this paper?

10.1158/1538-7445.am10-lb-31. The permanent link is https://doi.org/10.1158/1538-7445.am10-lb-31.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.